Section of Medical Ethics, Department of General Practice, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Department of Cardiology, Heart Center, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Crit Care. 2018 Sep 13;22(1):212. doi: 10.1186/s13054-018-2153-3.
Sudden cardiac arrest (SCA) accounts for half of all cardiac deaths in Europe. In recent years, large-scale SCA registries have been set up to enable observational studies into risk factors and the effect of treatment approaches. The increasing scale and variety of data sources, coupled with the implementation of a new European data protection legal framework, causes researchers to struggle with how to handle these 'big data'. Data protection in the SCA setting is especially complex since patients become at least temporarily incapacitated, and are thus unable to provide prospective informed consent, and because the majority of patients do not survive. A narrative review employing a systematic literature search was conducted to thematically analyse ethical aspects of non-interventional emergency medicine and critical care research. Although the identified issues may apply to a wider patient population, we describe them within the context of SCA research. Potential harms were found to include: privacy breaches, genetic discrimination and issues associated with the disclosure of individual findings, study design and application of research results. Measures proposed to mitigate harms were: alternative informed consent models including deferred or waived consent and data governance approaches promoting data security, responsible sharing and public engagement. The themes identified in this study may serve as a basis for a much-needed ethical framework regarding research with data from patients with acute and critical illness such as SCA.
心脏性骤停(SCA)占欧洲所有心脏性死亡的一半。近年来,已经建立了大规模的 SCA 登记处,以便能够对危险因素和治疗方法的效果进行观察性研究。不断增加的规模和数据源的多样性,加上新的欧洲数据保护法律框架的实施,使得研究人员难以处理这些“大数据”。SCA 环境中的数据保护尤其复杂,因为患者至少会暂时丧失能力,因此无法提供前瞻性的知情同意,而且大多数患者无法存活。本研究采用系统文献检索进行叙述性综述,以对非介入性急诊医学和重症监护研究的伦理方面进行主题分析。尽管已确定的问题可能适用于更广泛的患者群体,但我们将其描述为 SCA 研究的背景。潜在的危害包括:侵犯隐私、遗传歧视以及与个体研究结果的披露、研究设计和应用相关的问题。为减轻危害而提出的措施包括:替代的知情同意模式,包括延期或豁免同意,以及促进数据安全、负责任的共享和公众参与的数据治理方法。本研究确定的主题可以作为一个急需的关于 SCA 等急性和危重病患者数据研究的伦理框架的基础。